Zhejiang East Asia Pharmaceutical Co., Ltd. Class ASSE: 605177

"Zhejiang East-Asia Pharmaceutical Co., Ltd."Indicative Announcement on "East-Asia Convertible Bonds" Expected to Meet Conditions for Revising Conversion Price

Jul 2, 2026 · Issued by Zhejiang East Asia Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Indicative Announcement on "East-Asia Convertible Bonds" Expected to Meet Conditions for Revising Conversion Price

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Zhejiang East Asia Pharmaceutical Co., Ltd. Class A

"Zhejiang East-Asia Pharmaceutical Co., Ltd."Announcement on Repurchasing and Canceling Restricted Stocks Granted to Some Incentive Objects But Not Yet Lifted from Sales RestrictionsJul 1
Announcement on 2026 Interest Payment of "East-Asia Convertible Bonds"Jun 30
Announcement on SSE’s Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual ReportJun 24
Announcement on 2026 Follow-up Rating Results of Convertible Corporate Bonds Issued to Non-specific ObjectsJun 19

All Zhejiang East Asia Pharmaceutical Co., Ltd. Class A news releases